Minerva Capital

Minerva Capital, S.L. is a private equity firm based in Madrid, Spain, founded in 2004. The firm specializes in investing in buyouts of small and medium-sized companies across various industry sectors, including B2B, B2C, manufacturing, life sciences, beauty, e-commerce, health technology, and robotics. Minerva Capital typically invests between €4 million and €12 million in businesses with enterprise valuations ranging from €10 million to €50 million, and between €0.5 million and €4 million in special situations. The firm aims to acquire controlling positions and usually takes a seat on the board of directors of its portfolio companies, focusing on investments that can be exited within four to six years. In addition to traditional private equity investments, Minerva Capital offers assistance in refinancing, restructuring, growth capital, and acquisitions, ensuring a tailored approach to meet the needs of their clients.

Peter Bendel

Partner

David N. Bendel

Managing Partner

Alfonso Lopez-Quesada

Founding Partner

2 past transactions

Tract

Seed Round in 2020
Tract is an online educational platform designed specifically for children aged 8 and older, focusing on student-directed learning. The platform provides unlimited access to a diverse library of engaging courses, covering topics such as video game development and sports writing, along with vibrant weekly live events led by accomplished creators and mentors. This approach encourages children to explore their passions through real-world lessons, fostering essential skills and a mindset suited for 21st-century challenges. Founded on the TRICK philosophy—Trust, Respect, Independence, Collaboration, and Kindness—Tract aims to empower young learners to become innovators and global citizens. The company’s mission is rooted in the belief that children are capable of more than commonly perceived and that education should prioritize creativity and self-directed learning over standardization. By addressing issues such as the achievement gap and career readiness, Tract seeks to create a more equitable educational landscape that nurtures the next generation of leaders.

Genoclinics Biotech

Acquisition in 2012
Genoclinics offers a global solution to all human genetics for health professionals, the global solution includes all the stages: Prevention (Study of the probability of suffering a disease), Genetic Diagnosis (study of the genetics of a disease that is suffered) and pharmacogenetics, oriented to treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.